Delphinus Venture Capital — 2026 Investments

2 investments dated 2026 · listed companies and verified rows first · show all

Alcolasealcolase.com inMay 2026

Alcolase is a biotech company developing science-based solutions for people with alcohol intolerance, a genetic condition affecting hundreds of millions of people, particularly in East Asia.

BiotechConsumerWellness & FitnessCopenhagen, DK

Mikkel Precht(Founder)in

Co-investorsAda Ventures Antler Antler Australia Elmehøj Ventures Selvedge Venture

Kvantifykvantify.com inMar 2026

Kvantify develops software that runs on both quantum computers and classical computing architectures (CPU/GPU) to solve chemistry and biology problems for molecular and drug discovery.

BiotechDeep TechQuantum ComputingKøbenhavn Ø, DK

Co-investorsQAI Ventures Redstone Tane Fund 2xN Balderton Capital BioCapital +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.